Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$105,000.00
Sep 1, 2013
Molecular structure of the Staphylococcal antibiotic resistance protein AAC(6')-Ie/APH(2'')-Ia: structural analysis as a starting point in combating clinical resistance
$135,000.00
Sep 1, 2013
The Translation of Pre-Clinical to Clinical Research: A Study of Publication Bias.
$499,547.00
Aug 1, 2013
Measuring and modeling tumour evolution from next generation sequencing data: enabling clinical study of clonal diversity in cancer patients
$180,000.00
Jul 1, 2013
BRUISE CONTROL-2: A randomized controlled trial to investigate whether a strategy of Continued versus Interrupted Dabigatran at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events, leads to a reduction in the incidence of clinically significant hematoma
$140,000.00
Jul 1, 2013
Association Between Times to Administration of Adjuvant Chemotherapy and Outcomes in Early Breast Cancer: Analysis of Adjuvant Studies Conducted by NCIC Clinical Trials Group
$300,000.00
Jul 1, 2013
Biology and clinical significance of the tumour microenvironment in lymphoid cancers
$140,000.00
Jun 1, 2013
The influence of air pollution on asthma development and exacerbations : A translational research approach using human clinical exposures and mechanistic in vitro studies.
$1,960,606.00
Jun 1, 2013
GET-FACTS: Genetics, Environment and Therapies: Food Allergy Clinical Tolerance Studies
$199,845.00
Jun 1, 2013
Development, testing and feasibility of an interprofessional shared decision-making and goal-setting decision aid for patients with diabetes in clinical care
$674,422.00
Jun 1, 2013
Implementation and evaluation of a clinical pathway for chronic kidney disease in primary care